Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
Open-market buys, last 90 days
$627,549
in 5 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$627,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 Cook Robert Christopher Chief Operating& Legal Officer Purchase +121,575 $0.46 $56K 135,300
2025-09-30 Cook Robert Christopher Chief Operating & Legal Office Purchase +13,725 $2.91 $40K 13,725
2025-04-17 Cook Robert Christopher Chief Operating & Legal Office Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-09-06 Cook Robert Christopher SVP & General Counsel Grant or award · Stock Option (Right to Buy) +100,000 100,000
2024-05-20 Cook Robert Christopher SVP & General Counsel Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-10-03 Cook Robert Christopher SVP & General Counsel Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-10-28 Cook Robert Christopher SVP & General Counsel Grant or award · Employee Stock Option (right to buy) +100,000 $36.76 $3.7M 100,000

Page 1 of 1 · 7 trades